SCHEMBL27048660

SCHEMBL27048660

O=NP(=O)(O)OC[C@@H]1CCCO1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.45
POLB P06746 1/20 0.45
ALDH1A1 P00352 2/20 0.43
ANPEP P15144 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
USP2 O75604 1/20 0.35
MCL1 Q07820 1/20 0.35
HPGD P15428 2/20 0.34
TP53 P04637 1/20 0.34
ALOX12 P18054 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27048528 0.83 LMNA (0.44) LMNAPOLBALDH1A1ANPEPSMN1; SMN2
SCHEMBL23602333 0.82 LMNA (0.50) LMNAPOLBALDH1A1ANPEPSMN1; SMN2
SCHEMBL17525783 0.82 LMNA (0.50) LMNAPOLBALDH1A1ANPEPSMN1; SMN2
SCHEMBL9807555 0.82 LMNA (0.50) LMNAPOLBALDH1A1ANPEPSMN1; SMN2
SCHEMBL9231216 0.81 LMNA (0.49) LMNAPOLBALDH1A1ANPEPSMN1; SMN2
SCHEMBL21473264 0.79 LMNA (0.47) LMNAPOLBALDH1A1ANPEPSMN1; SMN2
SCHEMBL5956975 0.78 LMNA (0.49) LMNAPOLBALDH1A1ANPEPSMN1; SMN2
SCHEMBL19125739 0.77 LMNA (0.45) LMNAPOLBALDH1A1ANPEPSMN1; SMN2
SCHEMBL24393531 0.77 LMNA (0.45) LMNAPOLBALDH1A1ANPEPSMN1; SMN2
SCHEMBL23450919 0.75 LMNA (0.50) LMNAPOLBALDH1A1ANPEPSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4028021-B1 USE OF NMN FOR THE PREVENTION AND/OR TREATMENT OF PAIN, AND CORRESPONDING COMPOSITIONS NUVAMID SA (CH) 2024-01-24 EP disclosed